The Week in Review: April 6 – April 13, 2018

Friday, April 13, 2018 News Recap: Canada: Initiative aims to treat Hepatitis C in Alberta patients who also have HIV. A long-term effort to eliminate Hepatitis C as a public health threat is underway in Alberta, where a new program aims to provide medications to one particularly vulnerable group of patients. NOTE: In Alberta, coverage has been expanded as of April 1 to include all patients with hepatitis C. Previously, coverage was provided only to...

Non-profit’s $300 hepatitis C cure as effective as $84,000 alternative

71 million people stand to benefit from reduced price treatment for virus which can lead to liver cirrhosis, cancer and death. An affordable hepatitis C treatment has been shown to be safe and effective, with very high cure rates for patients including hard-to-treat cases, in interim clinical trial results that offer hope to the 71 million people living with the disease worldwide. The treatment is expected to cost $300 for 12 weeks, or $3.50 per day, i...

Hepatitis C treatment for under $300 coming soon

A hepatitis C treatment that costs less than $300 – a fraction of the $80,000-plus price charged by major drugmakers – has been successfully tested in Egypt and is expected to be available in the next one to two years. The Drugs for Neglected Diseases initiative (DNDi), a not-for-profit organisation, has teamed up with the Egyptian drugmaker Pharco Pharmaceuticals to bring a combination treatment of two hepatitis C tablets, ravidasvir and sofosbuvir, to...